DECIPHERA PHARMACEUT

DCPH
Real-time Estimate Quote. Real-time Estimate  - 01/21 11:34:05 am
8.305USD +1.90%

Deciphera to Cut Workforce by 35%; to Discontinue Rebastinib Program; to Extend Cash Runway into 2024

11/30/2021 | 09:00am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover